Atypical antipsychotic drugs in nonschizophrenic psychiatric disorders (Q34108447)

31 July 2017

1 reference

title

Atypical antipsychotic drugs in nonschizophrenic psychiatric disorders (English)

1 reference

31 July 2017

Zarate CA

1

1 reference

31 July 2017

Vemuri M

series ordinal

2

1 reference

31 July 2017

Cavanagh S

series ordinal

3

1 reference

31 July 2017

Land M

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Current Psychiatry Reports

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

291-297

1 reference

Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-000-0070-Y

Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders

21 January 2018

1 reference

12 December 2020

Treatment of Refractory Rapid Cycling Bipolar Disorder With Risperidone

1 reference

12 December 2020

Clozapine for treatment-refractory mania

1 reference

12 December 2020

Results and side effects of treatment with clozapine (leponex R)

1 reference

12 December 2020

Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group

1 reference

12 December 2020

Risperidone in the treatment of mania

1 reference

12 December 2020

Olanzapine response in psychotic depression

1 reference

12 December 2020

Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder

1 reference

12 December 2020

Acute treatment of bipolar disorder with adjunctive risperidone in outpatients

1 reference

12 December 2020

Clozapine in the treatment of refractory psychotic mania

1 reference

12 December 2020

Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder

1 reference

12 December 2020

Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome

1 reference

12 December 2020

Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up

1 reference

12 December 2020

Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial

1 reference

12 December 2020

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial

1 reference

12 December 2020

Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.

1 reference

12 December 2020

Clinical predictors of acute response with quetiapine in psychotic mood disorders

1 reference

12 December 2020

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

1 reference

12 December 2020

Clinical predictors of acute response with olanzapine in psychotic mood disorders.

1 reference

12 December 2020

Clozapine treatment of borderline patients: a preliminary study

1 reference

12 December 2020

Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders

1 reference

12 December 2020

Clozapine in severe mood disorders

1 reference

12 December 2020

Olanzapine in treatment-resistant bipolar disorder

1 reference

12 December 2020

Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach

1 reference

12 December 2020

Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania

1 reference

12 December 2020

10.1007/S11920-000-0070-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1035277693

0 references

1 reference